Your session is about to expire
← Back to Search
Behavioural Intervention
Effects of Osteopathic Manipulative Therapy on Arrhythmias
N/A
Waitlist Available
Led By Todd Cohen, MD
Research Sponsored by New York Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month from enrollment.
Summary
This trial is testing a hands-on treatment called Osteopathic Manipulative Medicine (OMM) on patients with irregular heartbeats. The goal is to see if this treatment can reduce the number of irregular heartbeats by improving overall body function. Patients will receive either the OMM treatment or another type of evaluation to compare the results.
Eligible Conditions
- Arrhythmia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month from enrollment.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month from enrollment.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Decrease in Cardiac Events
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Osteopathic Manipulative TreatmentExperimental Treatment1 Intervention
Group A will receive osteopathic treatment by NMM/OMM board certified attending physicians. The protocol for the OMT intervention group is based on the guidelines set forth previously in textbooks. The protocol will last 25 minutes total, with 10 minutes for the evaluation and 15 minutes for treatment. The protocol will start in ribs so as to not exacerbate any tachyarrhythmias with rib raising, thoracic myofascial release, and a pectoralis lift. The investigator will then proceed with opening the thoracic inlet, cervical myofascial release, suboccipital release, and then end by checking for and treating Chapman's points. The physician will submit their osteopathic evaluation and fill out a form in order to determine if certain arrhythmias have an associated trigger point.
Group II: Light Touch TreatmentPlacebo Group1 Intervention
Group B will receive a light touch treatment, based on previous research done studying heart rate variability and OMM, where sham treatment was utilized. The protocol consisted of contacting the right ankle, left knee, right hip, diaphragm, right shoulder, neck, and cranium for precisely two minutes each, with the goal of preventing placebo autonomic nervous system stimulation. The protocol is 25 minutes long, with 10 minutes for the evaluation and 15 minutes for treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Osteopathic Manipulative Treatment
2008
Completed Phase 4
~2570
Find a Location
Who is running the clinical trial?
New York Institute of TechnologyLead Sponsor
54 Previous Clinical Trials
2,164 Total Patients Enrolled
Todd Cohen, MDPrincipal InvestigatorNew York Institute of Technology College of Osteopathic Medicine